EBMT 2019 | Side effects of CAR T-cell therapy

Michael Schmitt

Michael Schmitt, MHBA, of University Hospital Heidelberg, Germany, explores the side effects of CD19 CAR T-cell therapy in patients with acute- and non-Hodgkin lymphoma. Prof. Schmitt was speaking at the European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting 2019, held in Frankfurt, Germany.

Share this video  
Similar topics